Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies.

Xu M, Zhang WL, Zhu Q, Zhang S, Yao YY, Xiang T, Feng QS, Zhang Z, Peng RJ, Jia WH, He GP, Feng L, Zeng ZL, Luo B, Xu RH, Zeng MS, Zhao WL, Chen SJ, Zeng YX, Jiao Y.

Theranostics. 2019 Jan 30;9(4):1115-1124. doi: 10.7150/thno.29622. eCollection 2019.

2.

Analysis of Epstein-Barr Virus Genomes and Expression Profiles in Gastric Adenocarcinoma.

Borozan I, Zapatka M, Frappier L, Ferretti V.

J Virol. 2018 Jan 2;92(2). pii: e01239-17. doi: 10.1128/JVI.01239-17. Print 2018 Jan 15. Erratum in: J Virol. 2018 Apr 27;92 (10 ):.

3.

Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.

Tu C, Zeng Z, Qi P, Li X, Yu Z, Guo C, Xiong F, Xiang B, Zhou M, Gong Z, Liao Q, Yu J, He Y, Zhang W, Li X, Li Y, Li G, Xiong W.

J Virol. 2017 Aug 10;91(17). pii: e00301-17. doi: 10.1128/JVI.00301-17. Print 2017 Sep 1.

4.

Genome-wide Analysis of Epstein-Barr Virus (EBV) Integration and Strain in C666-1 and Raji Cells.

Xiao K, Yu Z, Li X, Li X, Tang K, Tu C, Qi P, Liao Q, Chen P, Zeng Z, Li G, Xiong W.

J Cancer. 2016 Jan 1;7(2):214-24. doi: 10.7150/jca.13150. eCollection 2016.

5.

Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.

Church TM, Verma D, Thompson J, Swaminathan S.

J Virol. 2018 Feb 26;92(6). pii: e01794-17. doi: 10.1128/JVI.01794-17. Print 2018 Mar 15.

6.

Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology.

Liu P, Fang X, Feng Z, Guo YM, Peng RJ, Liu T, Huang Z, Feng Y, Sun X, Xiong Z, Guo X, Pang SS, Wang B, Lv X, Feng FT, Li DJ, Chen LZ, Feng QS, Huang WL, Zeng MS, Bei JX, Zhang Y, Zeng YX.

J Virol. 2011 Nov;85(21):11291-9. doi: 10.1128/JVI.00823-11. Epub 2011 Aug 31.

7.

Oncogenic induction of cellular high CpG methylation by Epstein-Barr virus in malignant epithelial cells.

Li L, Zhang Y, Guo BB, Chan FK, Tao Q.

Chin J Cancer. 2014 Dec;33(12):604-8. doi: 10.5732/cjc.014.10191. Epub 2014 Oct 17.

8.

Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.

Ramayanti O, Juwana H, Verkuijlen SA, Adham M, Pegtel MD, Greijer AE, Middeldorp JM.

Int J Cancer. 2017 Jan 1;140(1):149-162. doi: 10.1002/ijc.30418. Epub 2016 Sep 23.

9.

Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.

Zhang Y, Wang H, Liu Y, Wang C, Wang J, Long C, Guo W, Sun X.

Biomed Pharmacother. 2018 Jun;102:1003-1014. doi: 10.1016/j.biopha.2018.03.114. Epub 2018 Apr 5.

PMID:
29710517
10.

Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples.

Kwok H, Wu CW, Palser AL, Kellam P, Sham PC, Kwong DL, Chiang AK.

J Virol. 2014 Sep;88(18):10662-72. doi: 10.1128/JVI.01665-14. Epub 2014 Jul 2. Erratum in: J Virol. 2015 Jan;89(1):886.

11.

Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.

Wong AM, Kong KL, Tsang JW, Kwong DL, Guan XY.

Cancer. 2012 Feb 1;118(3):698-710. doi: 10.1002/cncr.26309. Epub 2011 Jun 30.

12.

Quantitation of DNA methylation in Epstein-Barr virus-associated nasopharyngeal carcinoma by bisulfite amplicon sequencing.

Zhao W, Mo Y, Wang S, Midorikawa K, Ma N, Hiraku Y, Oikawa S, Huang G, Zhang Z, Murata M, Takeuchi K.

BMC Cancer. 2017 Jul 17;17(1):489. doi: 10.1186/s12885-017-3482-3.

13.

Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection.

Palser AL, Grayson NE, White RE, Corton C, Correia S, Ba Abdullah MM, Watson SJ, Cotten M, Arrand JR, Murray PG, Allday MJ, Rickinson AB, Young LS, Farrell PJ, Kellam P.

J Virol. 2015 May;89(10):5222-37. doi: 10.1128/JVI.03614-14. Epub 2015 Mar 18.

14.

High-throughput RNA sequencing-based virome analysis of 50 lymphoma cell lines from the Cancer Cell Line Encyclopedia project.

Cao S, Strong MJ, Wang X, Moss WN, Concha M, Lin Z, O'Grady T, Baddoo M, Fewell C, Renne R, Flemington EK.

J Virol. 2015 Jan;89(1):713-29. doi: 10.1128/JVI.02570-14. Epub 2014 Oct 29.

15.

[Epstein-Barr Virus Genome Replication as a Molecular Target for Cancer Therapy].

Noguchi K.

Yakugaku Zasshi. 2019;139(1):63-67. doi: 10.1248/yakushi.18-00164-1. Japanese.

16.

NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.

Verhoeven RJ, Tong S, Zhang G, Zong J, Chen Y, Jin DY, Chen MR, Pan J, Chen H.

J Virol. 2016 Jun 24;90(14):6475-88. doi: 10.1128/JVI.00613-16. Print 2016 Jul 15.

17.

Epstein-Barr virus infection and nasopharyngeal carcinoma.

Tsao SW, Tsang CM, Lo KW.

Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732). pii: 20160270. doi: 10.1098/rstb.2016.0270. Review.

18.

A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA.

Majerciak V, Yang W, Zheng J, Zhu J, Zheng ZM.

J Virol. 2019 Jan 4;93(2). pii: e01593-18. doi: 10.1128/JVI.01593-18. Print 2019 Jan 15.

PMID:
30355690
19.

Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.

Tempera I, De Leo A, Kossenkov AV, Cesaroni M, Song H, Dawany N, Showe L, Lu F, Wikramasinghe P, Lieberman PM.

J Virol. 2015 Oct 14;90(1):345-55. doi: 10.1128/JVI.02318-15. Print 2016 Jan 1.

20.

The synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cells.

Fang CY, Huang SY, Wu CC, Hsu HY, Chou SP, Tsai CH, Chang Y, Takada K, Chen JY.

PLoS One. 2012;7(9):e44810. Epub 2012 Sep 14.

Supplemental Content

Support Center